2016_Head & Neck COURSE BOOK

NPC 9902 TRIAL Hong Kong ‐  –  • 4 arm trial  • T3‐4 N0‐1  • N=189 (planned 464) • >66 Gy at 2 Gy per fraction – Five vs. six fractions/week • Chemotherapy – ±concurrent cisplatin plus adjuvant cisplatin and  5‐fluorouracil (Intergroup 0099 regimen)

Lee A, Int. J. Radiation Oncology Biol. Phys., Vol. 66, No. 1, pp. 142–151, 2006